United States Stroke Recovery Medical Device Company Mobia Medical Nasdaq IPO Share Price Decreased -21.6% on Day 1 Trading (8/5/26: IPO Price: $15, Closing $11.75) to $430 Million Market Value & Raised $150 Million in IPO, Co-Founded in 2007 as MicroTransponder by Jordan Curnes
9th May 2026 | Hong Kong
United States stroke recovery medical device company Mobia Medical Nasdaq IPO share price decreased –21.6% on day 1 trading (8/5/26: IPO Price: $15, Closing $11.75) to $430 million market value, and raised $150 million in the IPO. In 2026 May, Mobia Medical Nasdaq IPO is raising $150 million at $549 million valuation, with expected IPO listing on 8th May 2026. Mobia Medical was co-founded in 2007 as MicroTransponder by Jordan Curnes. Mobia Medical – Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically-validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
“ United States Stroke Recovery Medical Device Company Mobia Medical Nasdaq IPO Share Price Decreased -21.6% on Day 1 Trading (8/5/26: IPO Price: $15, Closing $11.75) to $430 Million Market Value & Raised $150 Million in IPO, Co-Founded in 2007 as MicroTransponder by Jordan Curnes “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
United States Stroke Recovery Medical Device Company Mobia Medical Nasdaq IPO to Raise $150 Million at $549 Million Valuation with Expected IPO Listing on 8th May 2026, Co-Founded in 2007 as MicroTransponder by Jordan Curnes
8th May 2026 – United States stroke recovery medical device company Mobia Medical Nasdaq IPO is raising $150 million at $549 million valuation, with expected IPO listing on 8th May 2026. Mobia Medical was co-founded in 2007 as MicroTransponder by Jordan Curnes. Mobia Medical – Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically-validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
